S. Schuster

437 total citations
11 papers, 330 citations indexed

About

S. Schuster is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, S. Schuster has authored 11 papers receiving a total of 330 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 4 papers in Molecular Biology and 3 papers in Immunology. Recurrent topics in S. Schuster's work include CAR-T cell therapy research (3 papers), Sarcoma Diagnosis and Treatment (2 papers) and Viral Infectious Diseases and Gene Expression in Insects (2 papers). S. Schuster is often cited by papers focused on CAR-T cell therapy research (3 papers), Sarcoma Diagnosis and Treatment (2 papers) and Viral Infectious Diseases and Gene Expression in Insects (2 papers). S. Schuster collaborates with scholars based in United States, Switzerland and India. S. Schuster's co-authors include Sunita D. Nasta, Alison W. Loren, Donald E. Tsai, Edward A. Stadtmauer, Selina M. Luger, David Porter, Bruce L. Levine, Alexander E. Perl, Elizabeth Veloso and Stephen G. Emerson and has published in prestigious journals such as Blood, Cancer and Journal of Hepatology.

In The Last Decade

S. Schuster

10 papers receiving 327 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S. Schuster United States 6 199 124 123 79 50 11 330
Alessandro Previtali United States 7 257 1.3× 111 0.9× 76 0.6× 101 1.3× 27 0.5× 18 374
Alessandro Crotta United States 7 273 1.4× 121 1.0× 55 0.4× 99 1.3× 28 0.6× 26 369
Bryan Do United States 6 187 0.9× 79 0.6× 53 0.4× 32 0.4× 63 1.3× 7 288
Matthew L. Ulrickson United States 8 313 1.6× 156 1.3× 65 0.5× 28 0.4× 47 0.9× 35 401
Marie-Elisabeth Goebeler Germany 6 324 1.6× 197 1.6× 110 0.9× 41 0.5× 35 0.7× 7 392
Carlota Calvo Spain 7 189 0.9× 66 0.5× 86 0.7× 158 2.0× 24 0.5× 14 404
Edwin Kingsley United States 8 155 0.8× 122 1.0× 50 0.4× 98 1.2× 17 0.3× 25 301
Rodica Morariu-Zamfir United States 8 232 1.2× 110 0.9× 96 0.8× 104 1.3× 14 0.3× 15 385
Elizabeth Budde United States 9 161 0.8× 63 0.5× 48 0.4× 88 1.1× 10 0.2× 26 275
Suzanne Fanning United States 9 183 0.9× 182 1.5× 48 0.4× 65 0.8× 21 0.4× 44 320

Countries citing papers authored by S. Schuster

Since Specialization
Citations

This map shows the geographic impact of S. Schuster's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Schuster with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Schuster more than expected).

Fields of papers citing papers by S. Schuster

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Schuster. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Schuster. The network helps show where S. Schuster may publish in the future.

Co-authorship network of co-authors of S. Schuster

This figure shows the co-authorship network connecting the top 25 collaborators of S. Schuster. A scholar is included among the top collaborators of S. Schuster based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Schuster. S. Schuster is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Chong, Elise A., Bruce L. Levine, & S. Schuster. (2020). Clinical outcomes for anti-CD19 CAR T cell (CTL019) products not meeting commercial release specifications. Cytotherapy. 22(5). S29–S29. 2 indexed citations
2.
3.
Siddiqi, Tanya, Jeremy S. Abramson, Hannah Lee, et al.. (2019). SAFETY OF LISOCABTAGENE MARALEUCEL GIVEN WITH DURVALUMAB IN PATIENTS WITH RELAPSED/REFRACTORY AGGRESSIVE B‐CELL NON HODGKIN LYMPHOMA: FIRST RESULTS FROM THE PLATFORM STUDY. Hematological Oncology. 37(S2). 171–172. 24 indexed citations
4.
Limaye, Sewanti, Timothy Crook, Anantbhushan Ranade, et al.. (2019). Circulating tumour associated cells in esophageal cancers are resistance educated per previous chemo treatments. Annals of Oncology. 30. vii14–vii14. 1 indexed citations
5.
Chong, Elise A., S. Schuster, Stephan A. Grupp, et al.. (2019). Impact of CAR T-cell product viability on B-cell lymphoid malignancy outcomes. Cytotherapy. 21(5). S19–S19. 1 indexed citations
6.
Schuster, S., Matthew D. McGeough, Casey D. Johnson, et al.. (2017). Apoptosis signal-regulating kinase 1 (ASK1) inhibition reduces liver fibrosis and apoptosis in a NLRP3 mutant model of NASH. Journal of Hepatology. 66(1). S608–S609. 5 indexed citations
7.
8.
Svoboda, Jakub, Charalambos Andreadis, Rebecca Elstrom, et al.. (2006). Prognostic value of FDG-PET scan imaging in lymphoma patients undergoing autologous stem cell transplantation. Bone Marrow Transplantation. 38(3). 211–216. 68 indexed citations
9.
Porter, David, Bruce L. Levine, Nancy Bunin, et al.. (2005). A phase 1 trial of donor lymphocyte infusions expanded and activated ex vivo via CD3/CD28 costimulation. Blood. 107(4). 1325–1331. 176 indexed citations
10.
Kossev, Plamen, Puthiyaveettil N. Raghunath, Adam Bagg, et al.. (2001). SHP-1 Expression by Malignant Small B-Cell Lymphomas Reflects the Maturation Stage of Their Normal B-Cell Counterparts. The American Journal of Surgical Pathology. 25(7). 949–955. 15 indexed citations
11.
Jakubowski, Ann A., Michael S. Gordon, Agostino Tafuri, et al.. (1995). A pilot study of the biologic and therapeutic effects of granulocyte colony-stimulating factor (filgrastim) in patients with acute myelogenous leukemia.. PubMed. 9(11). 1799–804. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alessandro Previtali Breakdown of academic impact, for papers by Alessandro Crotta Breakdown of academic impact, for papers by Bryan Do Breakdown of academic impact, for papers by Matthew L. Ulrickson Breakdown of academic impact, for papers by Marie-Elisabeth Goebeler Breakdown of academic impact, for papers by Carlota Calvo Breakdown of academic impact, for papers by Edwin Kingsley Breakdown of academic impact, for papers by Rodica Morariu-Zamfir Breakdown of academic impact, for papers by Elizabeth Budde Breakdown of academic impact, for papers by Suzanne Fanning
Rankless by CCL
2026